NephroPlus IPO Opens: India's Largest Dialysis Provider; Long-Term Buy?

• NephroPlus IPO opened on December 10 and closes on December 12.
• The company is India's largest provider of dialysis and related services, with 519 clinics globally.
• The IPO price band is ₹438-₹460 per share, aiming to raise ₹871 crore.
• NephroPlus focuses on Tier 2 and Tier 3 cities, with 77% of its clinics in these areas.
• Long-term investors may consider investing in the IPO.

Why It Matters: Invest in NephroPlus, India's top dialysis provider, for long-term healthcare growth.